CloudTag appoints Amit Ben-Haim to its Board as Executive Director in charge of Corporate Development

– UK, London – CloudTag (CTAG:LN), which develops personal performance monitoring for the professional sports and consumer wellbeing markets, is pleased to announce that it has appointed Amit Ben-Haim as Director of Corporate Development with immediate effect.

CloudTag has appointed Amit as an Executive Director of the Company on a full-time basis, to reflect the true potential of his contribution going forward in the next phase of the Company’s development. Amit will be involved in the on-going growth, development and expansion of the Company, both on a commercial and corporate basis.

Prior to this appointment, Amit was engaged as a Consultant to CloudTag, making introductions to investors and other partners in the areas of finance, technology and consumer health and wellbeing. He has a proven track record as a successful entrepreneur establishing, leading and expanding companies through to trade sale exits as co-founder, executive and non-executive director. In 1993, he co-founded Biosense Inc., a medical devices company which was sold to Dow Jones-listed Johnson & Johnson in 1997 for $485 million. In 1996, he co-established Impulse Dynamics Inc., another medical devices company, which ultimately licensed its cardiac contractility technology to NYSE-listed Guidant Corporation and in 1998 he was one of several founders of Odigo Inc., a communications company specialising in instant messaging platforms, which was sold in 2000 to NASDAQ-listed Comverse Inc.

Commenting, Tony Reeves, Non-Executive Chairman: “I am delighted that Amit has agreed to join the Board of Directors and we look forward to him becoming an integral part of the business going forward.”

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.